The opening price for Bio-Path Holdings, Inc.

The opening price for Bio-Path Holdings, Inc. (NASDAQ:BPTH) was $0 and the volume amounted to 1.41 million shares which compares with the average volume of 0.47 million shares. The company stock experienced a 3.26% move to arrive at $0.47.

Bio-Path Holdings, Inc. (BPTH) Analyst Opinion

Bio-Path Holdings, Inc. has a consensus outperform rating from 2 Wall Street analysts, and the number of shares currently sold short amount to at least 2.71% of shares outstanding. The stock spiked 15.85% last month and is down -64.81 this year. Wall Street is only getting more bullish on the stock, with 2 of analysts who cover BPTH having a buy-equivalent rating. Analysts have placed a $4.5 price target on Bio-Path Holdings, Inc., suggesting a 857.45% gain from recent close. It’s currently trading about -68.33% below its 52-week high.

Bio-Path Holdings, Inc. (NASDAQ:BPTH) Intraday View

This stock (BPTH) is ahead of its 52-week low with 90%. Its last month’s stock price volatility remained 22.81% which for the week stands at 14.18%. The share price has moved forward from its 20 days moving average, trading at a distance of 18.58% and stays 38.5% away from its 50 days moving average. Over the last five days, shares have managed 15.83% gains and now is down -19.42% since hitting its 200-day moving average of $0.439. Bio-Path Holdings, Inc. (BPTH) has made its way to a 12-month decline of -59.05%.

Turning to Alcobra Ltd. (NASDAQ:ADHD), its shares were trading at $1.15 a retreat of $-0.06, on the trading floor. The stock, after opening at $0, touched a high of $1.14 before paring much of its gains. So far, analysts are sticking with their bearish recommendations with the consensus call at 3. Alcobra Ltd. has 0 buy ratings, 1 holds and 0 sells even after the stock tumbled -55.38% from its high of $1.29 to a $30.6 million market value through last close.

Alcobra Ltd. (ADHD) Consensus Price Target

The company’s consensus rating on Reuter’s scale remained unchanged from 3 to 3 during a month. Analysts set a 12-month price target of $1.67 a share. The target implies a 45.22% spike from where the shares are currently trading. Also, the current price highlights a discount of 73.91% to analysts’ high consensus price target.

Alcobra Ltd. (NASDAQ:ADHD) Intraday Trading

The counter witnessed a trading volume of 0.24 million shares versus an average volume of 0.28 million shares during last trading session. Its last month’s stock price volatility remained 15.41% which for the week approaches 8.61%. The lowest price the stock reached in the last trading day was $1.14 and compares with the $0.99 52-week low. The stock recovered 38.52% since its low point and has performed -45.24% year-to-date.